Reviewer disclosures A reviewer on this manuscript has disclosed that they have received speaking fees, consulting fees and research grants from Eli Lilly and Novo Nordisk
While earlier GHRPs like GHRP-6 activate multiple receptor pathways (affecting cortisol, prolactin, and appetite), Ipamorelin is studied for its receptor selectivityprimarily targeting GHSR-1a with minimal effects on other endocrine axes
A summary of the gut microbiota features associated with differential response to GLP-1 RA therapy in human studies is provided in Table 2
This article compares NAD+ and Sermorelin because both are widely researched by patients pursuing peptide therapy, but Perfect Bs prescription practice is limited to NAD+, CJC-1295/Ipamorelin, Tesamorelin, and the other peptides listed in our peptide treatment plan
Not intended for medicinal use.